Latest Insights - page 48 | BiopharmaTrend

Jimini Health Launches with $8M Seed Funding to Advance Mental Health Care

Stanford-based Jimini Health, a mental health startup founded in 2023, has announced its official launch with $8 million in seed funding from investors, including Zetta Venture Partners, LionBird, PsyMed, and …

Continue ›››

Axsome Therapeutics Announces Positive Phase 3 Results for Reboxetine in Narcolepsy

Axsome Therapeutics announced that its investigational treatment, AXS-12 (reboxetine), met the primary endpoint in the ENCORE Phase 3 trial. The trial demonstrated that AXS-12 significantly reduced the frequency of cataplexy …

Continue ›››

Novo Holdings Supports $135 Million Funding to Advance Adcendo’s Antibody-Drug Conjugate Development

Novo Holdings has joined a $135 million Series B financing round for Adcendo, a clinical-stage biotechnology company headquartered in Copenhagen, Denmark. Adcendo is focused on developing first-in-class antibody-drug conjugates (ADCs) …

Continue ›››

Valence Labs and Recursion Launch OpenQDC: The Largest Public Quantum Mechanical Dataset for ML Research

Researchers at Valence Labs, powered by Recursion, have introduced OpenQDC (Open Quantum Data Commons), an extensive, publicly accessible quantum mechanical dataset. OpenQDC is designed to accelerate machine learning in molecular …

Continue ›››

Roche Expands Cell Therapy Portfolio with $1.5 Billion Poseida Therapeutics Acquisition

Swiss pharmaceutical giant Roche has announced its acquisition of Poseida Therapeutics, a San Diego-based biotech company specializing in next-generation cell therapies. The deal, valued at up to $1.5 billion, is …

Continue ›››

A New Genetic Insight into Mitochondrial DNA Depletion Syndrome

Japanese researchers have identified a novel genetic cause for hepatocerebral mitochondrial DNA depletion syndrome (MTDPS), linking it to variants in the MICOS10 gene. This finding provides valuable insight into the …

Continue ›››

Communication, Staffing, Technology: The Persistent Barriers in Clinical Trials

Today, we’re diving into the results of Advarra’s 2024 Site-Sponsor-CRO Collaboration Survey, which highlights three major barriers hindering collaboration in clinical trials: communication, staffing, and technology. These challenges don’t just …

Continue ›››

M42 CEO Hasan Jasem Al Nowais Calls for a Global Shift Toward Preventative Healthcare

At the 7th Annual Longevity Forum in London, Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, delivered a keynote urging global leaders to embrace a preventative model …

Continue ›››

Lantern Pharma Expands Phase 2 Harmonic Clinical Trial to Japan and Taiwan

Lantern Pharma (NASDAQ: LTRN) has dosed the first patient in Japan as part of the expansion of its Phase 2 Harmonic clinical trial. The trial evaluates LP-300 in never-smokers with …

Continue ›››

Cradle Raises $73M for Gen-AI Protein Engineering

Cradle has secured $73 million in a Series B funding round led by IVP, bringing its total funding to over $100 million. This investment accelerates the adoption of Cradle’s generative …

Continue ›››

LongeVC Announces Investment in Glyphic Biotechnologies, Developing Single-Molecule Protein Sequencing

LongeVC has announced its investment in Glyphic Biotechnologies, a company developing single-molecule protein sequencing technology.

Continue ›››

Trogenix Emerges from Stealth with Precision Gene Therapy Platform to Target Aggressive Cancers

Trogenix Ltd has launched its Odysseus platform, leveraging Synthetic Super-Enhancer (SSE) technology to advance precision viral immunotherapy for aggressive cancers.

Continue ›››